Cargando…

Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment

AIM: To determine the number of mutations in the NS5A region of the hepatitis C virus (HCV) and its relationship to the response to antiviral therapy in patients with chronic hepatitis C genotype 1 who are non-responders to two or more treatments. METHODS: Sequences within HCV NS5A [PKR binding doma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz de Rueda, Paloma, Fuentes Rodríguez, José Manuel, Quiles Pérez, Rosa, Gila Medina, Ana, Martín Álvarez, Ana Belén, Casado Ruíz, Jorge, Ruíz Extremera, Angeles, Salmerón, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504369/ https://www.ncbi.nlm.nih.gov/pubmed/28740342 http://dx.doi.org/10.3748/wjg.v23.i25.4538

Ejemplares similares

Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C
por: Ruiz-Extremera, Ángeles, et al.
Publicado: (2013)

Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children
por: Ruiz-Extremera, A., et al.
Publicado: (2017)

Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

Seroprevalence and epidemiology of hepatitis B and C viruses in pregnant women in Spain. Risk factors for vertical transmission
por: Ruiz-Extremera, Ángeles, et al.
Publicado: (2020)

The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response
por: Muñoz de Rueda, P., et al.
Publicado: (2017)

Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
por: Schaefer, Esperance A K, et al.
Publicado: (2016)

Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients
por: Provazzi, Paola JS, et al.
Publicado: (2010)

Approaches to hepatitis C treatment and cure using NS5A inhibitors
por: Kohler, James J, et al.
Publicado: (2014)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

Akt Phosphorylation of Hepatitis C Virus NS5B Regulates Polymerase Activity and Hepatitis C Virus Infection
por: Sabariegos, Rosario, et al.
Publicado: (2021)

Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a
por: Anwar, Muhammad Ikram, et al.
Publicado: (2013)

Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease
por: Amin, Kawa, et al.
Publicado: (2017)

Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naïve Korean patients infected with genotype C2
por: Kim, Ji-Eun, et al.
Publicado: (2017)

Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals
por: Hu, Ke-Qin, et al.
Publicado: (2019)

The Investigation of Drug Resistance Substitutions in NS3 Protease Sequence of Hepatitis C Virus from Non-Responder Patients
por: Nejabat, Nargess, et al.
Publicado: (2019)

Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms
por: Chueca, Natalia, et al.
Publicado: (2016)

Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
por: Emara, Mohamed H, et al.
Publicado: (2011)

SAT-136 Investigation of Glycemic State among Responders to Hepatitis C Treatment
por: Elamir, Yasmine, et al.
Publicado: (2019)

Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort
por: Brandão, Ruben, et al.
Publicado: (2018)

Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
por: Wang, Xiao-Xiao, et al.
Publicado: (2018)

Palmitoylation of Hepatitis C Virus NS2 Regulates Its Subcellular Localization and NS2-NS3 Autocleavage
por: Wu, Ming-Jhan, et al.
Publicado: (2019)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis
por: Iyer, Janaki K, et al.
Publicado: (2017)

Planning the hepatitis C virus elimination in Cyprus: A modeling study
por: Gountas, Ilias, et al.
Publicado: (2021)

A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir
por: Fernandes Campos, Guilherme Rodrigues, et al.
Publicado: (2020)

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
por: Sagnelli, Caterina, et al.
Publicado: (2016)

Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
por: Tagnouokam-Ngoupo, Paul Alain, et al.
Publicado: (2019)

Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase
por: Beran, Rudolf K. F., et al.
Publicado: (2008)

Hepatitis C virus NS3‐4A inhibits the peroxisomal MAVS‐dependent antiviral signalling response
por: Ferreira, Ana R., et al.
Publicado: (2016)

Molecular models of NS3 protease variants of the Hepatitis C virus
por: da Silveira, Nelson JF, et al.
Publicado: (2005)

Hepatitis C Virus NS3 Inhibitors: Current and Future Perspectives
por: Salam, Kazi Abdus, et al.
Publicado: (2013)

Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus
por: Abian, Olga, et al.
Publicado: (2013)

Corrigendum: A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir
por: Fernandes Campos, Guilherme Rodrigues, et al.
Publicado: (2021)

354 Autoimmune Hepatitis Misdiagnosed as Hepatitis C Responding to Interferon/Ribavirine Therapy
por: Pijak, Michal R., et al.
Publicado: (2012)

Expression of Apoptosis Regulatory Markers in the Skin of Advanced Hepatitis-C Virus Liver Patients
por: El-Domyati, Moetaz, et al.
Publicado: (2012)

Performance of NS3, NS5a AND NS5b Hepatitis C Virus (HCV) Antiviral Resistance Sequencing Assays
por: Nutt, Jamie, et al.
Publicado: (2017)

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis
por: Cuypers, Lize, et al.
Publicado: (2018)

Gene expression and hepatitis C virus infection
por: Asselah, T, et al.
Publicado: (2009)

Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region
por: Nakatani, Sueli M., et al.
Publicado: (2010)

Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences
por: Win, Nan Nwe, et al.
Publicado: (2017)

Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients
por: Aldunate, Fabián, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_32ulr22ac6sdc9qth5ju77kr7u